BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30950377)

  • 21. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
    Ziogas DE; Kyrochristos ID; Roukos DH
    Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
    [No Abstract]   [Full Text] [Related]  

  • 22. [Genomic medicine].
    Nielsen FC
    Ugeskr Laeger; 2019 Apr; 181(7A):. PubMed ID: 30950375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation.
    Hunter JE; Irving SA; Biesecker LG; Buchanan A; Jensen B; Lee K; Martin CL; Milko L; Muessig K; Niehaus AD; O'Daniel J; Piper MA; Ramos EM; Schully SD; Scott AF; Slavotinek A; Sobreira N; Strande N; Weaver M; Webber EM; Williams MS; Berg JS; Evans JP; Goddard KA
    Genet Med; 2016 Dec; 18(12):1258-1268. PubMed ID: 27124788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics.
    Fiore RN; Goodman KW
    Curr Opin Oncol; 2016 Jan; 28(1):83-7. PubMed ID: 26569425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving health care through personal genomics.
    Rehm HL
    Nat Rev Genet; 2017 Apr; 18(4):259-267. PubMed ID: 28138143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.
    Hitomi Y; Tokunaga K
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(9):657-676. PubMed ID: 29129848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of genetic health professional - laboratory specialist interactions in diagnostic genomic sequencing.
    Vears DF; Sénécal K; Borry P
    Eur J Med Genet; 2020 Mar; 63(3):103749. PubMed ID: 31472303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine.
    Ipe J; Swart M; Burgess KS; Skaar TC
    Clin Transl Sci; 2017 Mar; 10(2):67-77. PubMed ID: 28213901
    [No Abstract]   [Full Text] [Related]  

  • 29. Application of advanced molecular technology in the diagnosis and management of genetic disorders in South Africa.
    Kotze M
    S Afr Med J; 2016 May; 106(6 Suppl 1):S114-8. PubMed ID: 27245544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.
    Allegretti M; Fabi A; Buglioni S; Martayan A; Conti L; Pescarmona E; Ciliberto G; Giacomini P
    J Exp Clin Cancer Res; 2018 Mar; 37(1):47. PubMed ID: 29506529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exome sequencing a review of new strategies for rare genomic disease research.
    Brown TL; Meloche TM
    Genomics; 2016 Oct; 108(3-4):109-114. PubMed ID: 27387609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities and challenges of whole-genome and -exome sequencing.
    Petersen BS; Fredrich B; Hoeppner MP; Ellinghaus D; Franke A
    BMC Genet; 2017 Feb; 18(1):14. PubMed ID: 28193154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting.
    Lee B; Tran B; Hsu AL; Taylor GR; Fox SB; Fellowes A; Marquis R; Mooi J; Desai J; Doig K; Ekert P; Gaff C; Herath D; Hamilton A; James P; Roberts A; Snyder R; Waring P; McArthur G
    Intern Med J; 2018 Jul; 48(7):786-794. PubMed ID: 29607586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next-generation sequencing applied to rare diseases genomics.
    Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
    Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
    Sheikine Y; Kuo FC; Lindeman NI
    J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Implementing next-generation sequencing for precision hematology/oncology].
    Maeda T
    Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A practical guide to filtering and prioritizing genetic variants.
    Jalali Sefid Dashti M; Gamieldien J
    Biotechniques; 2017 Jan; 62(1):18-30. PubMed ID: 28118812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
    Maggi E; Montagna C
    Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparing the next generation of genomicists: a laboratory-style course in medical genomics.
    Linderman MD; Bashir A; Diaz GA; Kasarskis A; Sanderson SC; Zinberg RE; Mahajan M; Shah H; Suckiel S; Zweig M; Schadt EE
    BMC Med Genomics; 2015 Aug; 8():47. PubMed ID: 26264128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.